EMA debuts NAM data sharing pilot amid animal testing divergence

Through the EMA's new pilot, stakeholders can secure access to feedback on their NAM from non-clinical experts. Through the pilot, stakeholders can secure access to feedback on their NAM from non-clinical experts. Global regulators are increasingly championing NAM use in non-clinical research amid a shift away from traditional animal testing. Credit: ProStockStudio / Shutterstock.com. The European Medicines Agency (EMA) has debuted a new voluntary pilot scheme designed to help preclinical toxicologists secure feedback on data generated from new approach methodologies (NAMs), as global regulators champion the move away from animal testing in preclinical research. Under the new voluntary data submission…

Source: Clinical Trials Arena